The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7728-7735

  Shao, Wen Hai ^a   Eisenberg, Robert A ^a   Cohen, Philip L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHROMATIN AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE MER; UNCLASSIFIED DRUG; MERTK PROTEIN, MOUSE; ONCOPROTEIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL TRANSFER; CHRONIC DISEASE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; GRAFT VS HOST DISEASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SELF TOLERANCE;

EID: 47249136911     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7728     Document Type: Article

References (27)

1. Gleichmann, E., E. H. VanEIven, and J. P. Vander Veen. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12: 152-159.
2. Portanova, J. P., R. E. Arndt, and B. L. Kotzin. 1988. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus: predominant reactivity with histone regions accessible in chromatin. J. Immunol. 140: 755-760.
3. Tse, H. Y., S. Kanamori, W. D. Walsh, and T. H. Hansen. 1985. The murine bml2 gene conversion provides evidence that T cells recognize predominantly la conformation. Proc. Natl. Acad. Sci. USA 82: 7058-7062.
4. Eisenberg, R., and A. Choudhury. 2004. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction. Methods Mol. Med. 102: 273-284.
5. Morris, S. C, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. J. Immunol. 144: 916-922.
6. 1 mice undergoing graft-versus-host reaction (GVHR). Adv. Exp. Med. Biol. 149: 669-677.
7. Graham, D. K., G. W. Bowman, T. L. Dawson, W. L. Stanford, H. S. Earp, and H. R. Snodgrass. 1995. Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. Oncogene 10: 2349-2359.
8. Scott, R. S., E. J. McMahon, S. M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H. S. Earp, and G. K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211.
9. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140.
10. Behrens, E. M., P. Gadue, S. Y. Gong, S. Garrett, P. L. Stein, and P. L. Cohen. 2003. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur. J. Immunol. 33: 2160-2167.
11. Hafizi, S., and B. Dahlback. 2006. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev. 17: 295-304.
12. Camenisch, T. D., B. H. Koller, H. S. Earp, and G. K. Matsushima. 1999. A novel receptor tyrosine kinase, Mer, inhibits TNF-α production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 162: 3498-3503.
13. Keating, A. K., D. B. Salzberg, S. Sather, X. Liang, S. Nickoloff, A. Anwar, D. Deryckere, K. Hill, D. Joung, K. K. Sawczyn, et al. 2006. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene 25: 6092-6100.
14. Georgescu, M. M., K. H. Kirsch, T. Shishido, C. Zong, and H. Hanafusa. 1999. Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-κB. Mol. Cell. Biol. 19: 1171-1181.
15. Fan, L., L. Dai, F. Shen, M. Y. Zhou, N. Z. Dong, and C. G. Ruan. 2007. [Expression of Mer on Jurkat cells and its anti-apoptosis effect.] Ai Zheng 26: 698-702.
16. Reap, E. A., N. J. Felix, P. A. Wolthusen, B. L. Kotzin, P. L. Cohen, and R. A. Eisenberg. 1995. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J. Immunol. 155: 5455-5462.
17. Radic, M. Z., S. M. Ibrahim, J. Rauch, S. A. Camper, and M. Weigert. 1995. Constitutive secretion of transgene-encodcd IgG2b autoantibodies leads to symptoms of autoimmune disease. J. Immunol. 155: 3213-3222.
18. Ibrahim, S. M, M. Weigert, C. Basu, J. Erikson, and M. Z. Radic. 1995. Light chain contribution to specificity in anti-DNA antibodies. J. Immunol 155: 3223-3233.
19. Choudhury, A., M. A. Maldonado, P. L. Cohen, and R. A. Eisenberg. 2005. The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J. Immunol. 174: 7600-7609.
20. Izui, S., R. A. Eisenberg, and F. J. Dixon. 1981. Subclass-restricted IgG poly-clonal antibody production in mice injected with lipid A-rich lipopolysaccha-rides. J. Exp. Med. 153: 324-338.
21. Chen, R, M. A. Maldonado, M. Madaio, and R. A. Eisenberg. 1998. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. J. Immunol. 161: 5880-5885.
22. 5 integrin-mediated phagocytosis of apoptotic cells. J. Cell Sci. 118:539-553.
23. Wu, Y., N. Tibrewal, and R. B. Birge. 2006. Phosphatidylscrine recognition by phagocytes: a view to a kill. Trends Cell Biol. 16: 189-197.
24. Ling, L., and H. J. Kung. 1995. Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase. Mol. Cell. Biol. 15: 6582-6592.
25. Ek, S., C. M. Hogerkorp, M. Dictor, M. Ehinger, and C. A. Borrebaeck. 2002. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res. 62: 4398-4405.
26. Yeoh, E. J., M. E. Ross, S. A. Shurtleff, W. K. Williams, D. Patel, R. Mahfouz, F. G. Behm, S. C. Raimondi, M. V. Relling, A. Patel, et al. 2002. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cells 1: 133-143.
27. Khan, J., M. L. Bittner, L. H. Saal, U. Teichmann, D. O. Azorsa, G. C. Gooden, W. J. Pavan, J. M. Trent, and P. S. Meltzer. 1999. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion on-cogene. Proc. Natl. Acad. Sci. USA 96: 13264-13269.